» Articles » PMID: 37138859

MicroRNA: Role in Macrophage Polarization and the Pathogenesis of the Liver Fibrosis

Overview
Journal Front Immunol
Date 2023 May 4
PMID 37138859
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophages, as central components of innate immunity, feature significant heterogeneity. Numerus studies have revealed the pivotal roles of macrophages in the pathogenesis of liver fibrosis induced by various factors. Hepatic macrophages function to trigger inflammation in response to injury. They induce liver fibrosis by activating hepatic stellate cells (HSCs), and then inflammation and fibrosis are alleviated by the degradation of the extracellular matrix and release of anti-inflammatory cytokines. MicroRNAs (miRNAs), a class of small non-coding endogenous RNA molecules that regulate gene expression through translation repression or mRNA degradation, have distinct roles in modulating macrophage activation, polarization, tissue infiltration, and inflammation regression. Considering the complex etiology and pathogenesis of liver diseases, the role and mechanism of miRNAs and macrophages in liver fibrosis need to be further clarified. We first summarized the origin, phenotypes and functions of hepatic macrophages, then clarified the role of miRNAs in the polarization of macrophages. Finally, we comprehensively discussed the role of miRNAs and macrophages in the pathogenesis of liver fibrotic disease. Understanding the mechanism of hepatic macrophage heterogeneity in various types of liver fibrosis and the role of miRNAs on macrophage polarization provides a useful reference for further research on miRNA-mediated macrophage polarization in liver fibrosis, and also contributes to the development of new therapies targeting miRNA and macrophage subsets for liver fibrosis.

Citing Articles

Regulation of immune cells by miR-451 and its potential as a biomarker in immune-related disorders: a mini review.

Wang F, Shi Z, Mu G Front Immunol. 2024; 15:1421473.

PMID: 39076992 PMC: 11284029. DOI: 10.3389/fimmu.2024.1421473.


Emerging role of exosomal microRNA in liver cancer in the era of precision medicine; potential and challenges.

El Hayek T, Alnaser-Almusa O, Alsalameh S, Alhalabi M, Sabbah A, Alshehri E Front Mol Biosci. 2024; 11:1381789.

PMID: 38993840 PMC: 11236732. DOI: 10.3389/fmolb.2024.1381789.


Long Non-coding RNAs Regulating Macrophage Polarization in Liver Cancer.

Jia D, He Y, Zhang Y Curr Pharm Des. 2024; 30(27):2120-2128.

PMID: 38859791 DOI: 10.2174/0113816128311861240523075218.


miR-27b-3p reduces muscle fibrosis during chronic skeletal muscle injury by targeting TGF-βR1/Smad pathway.

Yao H, Qian J, Bian X, Guo L, Tang K, Tao X J Orthop Surg Res. 2024; 19(1):329.

PMID: 38825706 PMC: 11145862. DOI: 10.1186/s13018-024-04733-9.


Macrophage polarization in spinal cord injury repair and the possible role of microRNAs: A review.

Wang J, Tian F, Cao L, Du R, Tong J, Ding X Heliyon. 2023; 9(12):e22914.

PMID: 38125535 PMC: 10731087. DOI: 10.1016/j.heliyon.2023.e22914.


References
1.
Song J, Yang P, Li X, Zhu X, Liu M, Duan X . Esophageal Cancer-Derived Extracellular Vesicle miR-21-5p Contributes to EMT of ESCC Cells by Disorganizing Macrophage Polarization. Cancers (Basel). 2021; 13(16). PMC: 8392810. DOI: 10.3390/cancers13164122. View

2.
Conte E . Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches. Pharmacol Ther. 2021; 234:108031. DOI: 10.1016/j.pharmthera.2021.108031. View

3.
Dewidar B, Meyer C, Dooley S, Meindl-Beinker A . TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells. 2019; 8(11). PMC: 6912224. DOI: 10.3390/cells8111419. View

4.
Tong F, Mao X, Zhang S, Xie H, Yan B, Wang B . HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumor radiosensitivity. Cancer Lett. 2020; 478:34-44. DOI: 10.1016/j.canlet.2020.02.037. View

5.
Qian M, Wang S, Guo X, Wang J, Zhang Z, Qiu W . Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways. Oncogene. 2019; 39(2):428-442. DOI: 10.1038/s41388-019-0996-y. View